These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 15485795

  • 21. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [Abstract] [Full Text] [Related]

  • 22. Alanine aminotransferase/aspartate aminotransferase ratio reversal and prolonged prothrombin time: a specific indicator of hepatic cirrhosis.
    Siddiqi AI, Siddiqeh M, Mehmood A, Siddiqui AM.
    J Ayub Med Coll Abbottabad; 2007 Aug; 19(3):22-4. PubMed ID: 18444585
    [Abstract] [Full Text] [Related]

  • 23. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J, Ryzlová M, Striteský J, Horák J.
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [Abstract] [Full Text] [Related]

  • 24. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E, Ulcay A, Tanoglu A, Kara M, Turhan V, Erdem H, Oncul O, Gorenek L.
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [Abstract] [Full Text] [Related]

  • 25. Can aspartate aminotransferase to platelet ratio index replace liver biopsy in chronic hepatitis C?
    El-Sayed R, Fahmy M, El Koofy N, El-Raziky M, El-Hawary M, Helmy H, El-Akel W, El-Hennawy A, El-Karaksy H.
    Trop Gastroenterol; 2011 Dec; 32(4):267-72. PubMed ID: 22696906
    [Abstract] [Full Text] [Related]

  • 26. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH, Xu XY, Tian GS, Yu YY.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):390-3. PubMed ID: 16677548
    [Abstract] [Full Text] [Related]

  • 27. Histopathological features of liver and its relation to serum transaminase levels in 91 cases of anti-HBe-positive chronic hepatitis B.
    Hasanjani Roushan MR, Hajiahmadi M, Shafaie S.
    Int J Clin Pract; 2005 Jul 14; 59(7):791-4. PubMed ID: 15963206
    [Abstract] [Full Text] [Related]

  • 28. Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults.
    Assy N, Minuk GY.
    Am J Gastroenterol; 2000 Jun 14; 95(6):1545-50. PubMed ID: 10894594
    [Abstract] [Full Text] [Related]

  • 29. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML.
    Liver Int; 2006 Nov 14; 26(9):1095-9. PubMed ID: 17032410
    [Abstract] [Full Text] [Related]

  • 30. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.
    Fung J, Lai CL, Fong DY, Yuen JC, Wong DK, Yuen MF.
    Liver Int; 2008 Dec 14; 28(10):1408-16. PubMed ID: 18482268
    [Abstract] [Full Text] [Related]

  • 31. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.
    Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, Forouzanfar MH, Abedian S, Tavangar SM, Mohamadkhani A, Ghoujeghi F, Estakhri A, Nouri N, Farzadi Z, Najjari A, Malekzadeh R.
    Am J Gastroenterol; 2006 Nov 14; 101(11):2537-45. PubMed ID: 17029616
    [Abstract] [Full Text] [Related]

  • 32. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
    Nyblom H, Björnsson E, Simrén M, Aldenborg F, Almer S, Olsson R.
    Liver Int; 2006 Sep 14; 26(7):840-5. PubMed ID: 16911467
    [Abstract] [Full Text] [Related]

  • 33. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.
    Gut; 2008 Apr 14; 57(4):500-6. PubMed ID: 18025069
    [Abstract] [Full Text] [Related]

  • 34. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec 14; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 35. Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C.
    Borroni G, Ceriani R, Cazzaniga M, Tommasini M, Roncalli M, Maltempo C, Felline C, Salerno F.
    Aliment Pharmacol Ther; 2006 Sep 01; 24(5):797-804. PubMed ID: 16918883
    [Abstract] [Full Text] [Related]

  • 36. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
    Taniguchi H, Iwasaki Y, Fujiwara A, Sakaguchi K, Moriya A, Yu PC, Takaki A, Fujioka S, Shimomura H, Shiratori Y.
    J Gastroenterol Hepatol; 2006 Jan 01; 21(1 Pt 2):281-7. PubMed ID: 16460487
    [Abstract] [Full Text] [Related]

  • 37. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.
    Fabris C, Smirne C, Toniutto P, Colletta C, Rapetti R, Minisini R, Falleti E, Pirisi M.
    Clin Biochem; 2006 Apr 01; 39(4):339-43. PubMed ID: 16487951
    [Abstract] [Full Text] [Related]

  • 38. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model.
    Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, Sung JJ.
    Am J Gastroenterol; 2005 Mar 01; 100(3):616-23. PubMed ID: 15743360
    [Abstract] [Full Text] [Related]

  • 39. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M, Idrees M, Nasir B, Raja AJ, Raza SM, Amin I, Rasul A, Tayyab GU.
    Eur J Gastroenterol Hepatol; 2014 Jul 01; 26(7):788-94. PubMed ID: 24781355
    [Abstract] [Full Text] [Related]

  • 40. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K, Wawrzynowicz-Syczewska M, Boroń-Kaczmarska A, Sych Z.
    Med Sci Monit; 2001 Jul 01; 7(5):962-5. PubMed ID: 11535942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.